Patanase (Olopatadine Hydrochloride Nasal) - Current Clinical Trials

Patanase Related Clinical Trials

Comparing Patient Satisfaction With Pataday or Bepreve [Recruiting]

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis [Recruiting]

Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis [Not yet recruiting]

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients [Recruiting]

Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age [Recruiting]

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis [Recruiting]

Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis [Recruiting]

Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis [Recruiting]

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial [Recruiting]

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients [Recruiting]

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients [Recruiting]

Allergic Eye Disease Tear Mediators [Recruiting]

Comparison of CL Wear Between Two Allergy Drops [Not yet recruiting]

An Open-label, Long-term Study, With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis [Not yet recruiting]

Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Not yet recruiting]